Ultimately, future work will focus on clinical trials that will advance CtBP inhibitors, evaluate their safety and efficacy in cancer patients, and explore their potential to be used in combination with other therapeutic approaches, facilitating their translation to clinical applications and providing new strategies and approaches for cancer therapy and the treatment of virus-associated tumors. The gene discussed is CTBP1; the disease is cancer.